WisdomTree BioRevolution Fund Rating → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free WDNA Stock Alerts $15.92 +0.10 (+0.63%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings WisdomTree BioRevolution Fund Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.WDNA Aggregate RatingModerate Buy2.69Holdings in WDNA have an aggregate rating of Moderate Buy based on 573 analyst ratings issued in the past year covering 47 companies (66.6% of the portfolio).WDNA Aggregate Price Target$21.3333.97% UpsideHigh Prediction$28.57Average Prediction$21.33Low Prediction$14.79Holdings in WDNA have an aggregate price target of $21.33 and a range of $14.79 to $28.57 covering 47 companies (66.6% of the portfolio).WDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy31 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by WisdomTree BioRevolution Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 WDNA Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.60%TWSTTwist Bioscience$41.90+2.6%3 of 5 stars3.00$42.50 1.4%6Positive News2.56%BPMCBlueprint Medicines$105.56-0.8%1 of 5 stars2.53$103.94 -1.5%17Positive News2.35%NTRANatera$106.53-3.3%2 of 5 stars3.00$98.47 -7.6%15Insider SellingNews Coverage2.13%GERNGeron$3.55+2.3%4 of 5 stars2.80$6.10 71.8%5Positive News2.06%LLYEli Lilly and Company$820.34+0.6%5 of 5 stars2.84$769.53 -6.2%19Insider Selling2.04%VCELVericel$47.70-1.0%0 of 5 stars3.00$46.80 -1.9%6Positive News1.94%IOVAIovance Biotherapeutics$8.88-1.3%4 of 5 stars3.00$24.64 177.4%10Analyst ForecastAnalyst Revision1.86%BBIOBridgeBio Pharma$28.01-2.9%5 of 5 stars2.92$47.62 70.0%12Analyst ForecastAnalyst Revision1.76%AGIOAgios Pharmaceuticals$36.34-3.2%2 of 5 stars2.50$35.00 -3.7%4Analyst UpgradeShort Interest ↓Analyst Revision1.63%FATEFate Therapeutics$3.68+6.7%5 of 5 stars2.14$6.58 78.9%14Short Interest ↓1.59%SRPTSarepta Therapeutics$129.86+4.3%5 of 5 stars2.80$164.00 26.3%15Analyst ForecastHigh Trading Volume1.46%VRTXVertex Pharmaceuticals$455.34+2.8%4 of 5 stars2.50$438.62 -3.7%24Analyst ForecastInsider SellingNews CoverageHigh Trading Volume1.43%DHRDanaher$256.80+1.6%4 of 5 stars2.64$267.31 4.1%14Short Interest ↑Positive NewsHigh Trading Volume1.37%MYGNMyriad Genetics$22.76+1.3%3 of 5 stars2.50$25.57 12.4%8Positive News1.37%AMGNAmgen$305.85+1.6%5 of 5 stars2.52$305.65 -0.1%21Short Interest ↑1.36%REGNRegeneron Pharmaceuticals$980.16+1.1%4 of 5 stars2.76$989.36 0.9%21Insider SellingHigh Trading Volume1.34%CRSPCRISPR Therapeutics$53.74-0.6%2 of 5 stars2.31$73.46 36.7%16Short Interest ↑Analyst Revision1.34%ARCTArcturus Therapeutics$38.81+0.9%3 of 5 stars3.00$64.86 67.1%7Short Interest ↓Positive News1.31%MRKMerck & Co., Inc.$125.54+0.8%4 of 5 stars2.58$131.33 4.6%12Dividend AnnouncementHigh Trading Volume1.30%CTLTCatalent$53.79+0.3%3 of 5 stars2.17$53.14 -1.2%12Analyst ForecastHigh Trading Volume1.28%DDDuPont de Nemours$82.16+0.9%5 of 5 stars2.58$91.09 10.9%12Analyst Upgrade1.27%AAgilent Technologies$130.41-0.8%4 of 5 stars2.56$137.19 5.2%16Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageHigh Trading Volume1.26%UTHRUnited Therapeutics$275.13+1.7%5 of 5 stars2.90$309.44 12.5%10Insider SellingHigh Trading Volume1.26%DARDarling Ingredients$40.40+2.3%4 of 5 stars2.80$70.80 75.2%10Positive NewsHigh Trading Volume1.26%DOWDOW$57.63+1.6%4 of 5 stars2.29$59.18 2.7%141.24%STOKStoke Therapeutics$14.62+6.1%4 of 5 stars2.88$20.57 40.7%8Analyst RevisionHigh Trading Volume1.21%TMOThermo Fisher Scientific$567.98+0.9%5 of 5 stars2.71$605.31 6.6%17Positive News1.21%VCYTVeracyte$20.75-1.1%3 of 5 stars2.60$27.50 32.5%51.21%GMABGenmab A/S$28.20+0.8%3 of 5 stars2.38$48.50 72.0%13Short Interest ↑1.20%RAREUltragenyx Pharmaceutical$40.14+3.9%5 of 5 stars2.93$90.67 125.9%14Analyst ForecastNews CoveragePositive NewsHigh Trading Volume1.18%RGENRepligen$149.09+0.6%5 of 5 stars2.89$197.75 32.6%9Positive NewsHigh Trading Volume1.16%AZNAstraZeneca$78.02+1.6%3 of 5 stars2.67$88.00 12.8%9Analyst ForecastShort Interest ↓1.16%QGENQiagen$43.26+1.5%4 of 5 stars2.56$50.95 17.8%91.16%TSNTyson Foods$57.25+1.2%4 of 5 stars2.11$60.22 5.2%9Short Interest ↑High Trading Volume1.14%ZTSZoetis$169.56+0.1%5 of 5 stars3.00$211.75 24.9%7Short Interest ↑1.12%FOLDAmicus Therapeutics$9.80-0.8%4 of 5 stars2.88$17.57 79.3%8Analyst ForecastAnalyst RevisionPositive NewsGap Up1.10%JNJJohnson & Johnson$146.67+1.0%5 of 5 stars2.38$174.07 18.7%13Analyst ForecastHigh Trading Volume1.10%TECHBio-Techne$77.19-0.1%4 of 5 stars2.73$81.00 4.9%111.09%NEONeoGenomics$13.71-2.1%3 of 5 stars2.90$19.78 44.3%10Positive News1.09%IONSIonis Pharmaceuticals$37.57+2.8%4 of 5 stars2.71$59.54 58.5%14Positive News1.07%BEAMBeam Therapeutics$23.82-1.1%1 of 5 stars2.38$40.18 68.7%13Positive News1.07%CTVACorteva$55.94+1.3%5 of 5 stars2.71$63.05 12.7%21Short Interest ↓Positive News1.06%LHLaboratory Co. of America$194.91+0.8%5 of 5 stars2.79$241.86 24.1%14Analyst Forecast1.03%RGNXREGENXBIO$14.355 of 5 stars2.83$38.64 169.2%12Analyst Upgrade0.97%MRNAModerna$142.55-5.9%3 of 5 stars2.24$126.46 -11.3%17Insider Selling0.96%EDITEditas Medicine$5.20+0.6%4 of 5 stars2.45$13.27 155.2%11Analyst ForecastAnalyst Revision0.95%ARWRArrowhead Pharmaceuticals$22.95+0.7%4 of 5 stars2.78$50.00 117.9%9Gap Up This page (BATS:WDNA) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsLEAKED: Jeff Bezos' $330 Million GambleBehind the MarketsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding WisdomTree BioRevolution Fund Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
